Increased anxiety in corticotropin-releasing factor type 2 receptor-null mice requires recent acute stress exposure and is associated with dysregulated serotonergic activity in limbic brain areas

[1]  E. Paul,et al.  Functional topography of serotonergic systems supports the Deakin/Graeff hypothesis of anxiety and affective disorders , 2013, Journal of psychopharmacology.

[2]  N. Coimbra,et al.  Differential involvement of dorsal raphe subnuclei in the regulation of anxiety- and panic-related defensive behaviors , 2012, Neuroscience.

[3]  Y. Li,et al.  Chronic social defeat up‐regulates expression of the serotonin transporter in rat dorsal raphe nucleus and projection regions in a glucocorticoid‐dependent manner , 2012, Journal of neurochemistry.

[4]  J. Vaughan,et al.  Chronic Activation of Corticotropin-Releasing Factor Type 2 Receptors Reveals a Key Role for 5-HT1A Receptor Responsiveness in Mediating Behavioral and Serotonergic Responses to Stressful Challenge , 2012, Biological Psychiatry.

[5]  M. Lebow,et al.  Susceptibility to PTSD-Like Behavior Is Mediated by Corticotropin-Releasing Factor Receptor Type 2 Levels in the Bed Nucleus of the Stria Terminalis , 2012, The Journal of Neuroscience.

[6]  C. Sandi,et al.  Evidence for biological roots in the transgenerational transmission of intimate partner violence , 2012, Translational Psychiatry.

[7]  G. Aston-Jones,et al.  A Septal-Hypothalamic Pathway Drives Orexin Neurons, Which Is Necessary for Conditioned Cocaine Preference , 2012, The Journal of Neuroscience.

[8]  G. Miller,et al.  Advances in tryptophan hydroxylase‐2 gene expression regulation: New insights into serotonin–stress interaction and clinical implications , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[9]  David L. Walker,et al.  EFFECTS OF CONTINUOUSLY ENHANCED CORTICOTROPIN RELEASING FACTOR EXPRESSION WITHIN THE BED NUCLEUS OF THE STRIA TERMINALIS ON CONDITIONED AND UNCONDITIONED ANXIETY , 2012, Molecular Psychiatry.

[10]  S. Maier,et al.  Uncontrollable, But Not Controllable, Stress Desensitizes 5-HT1A Receptors in the Dorsal Raphe Nucleus , 2011, The Journal of Neuroscience.

[11]  C. Winstanley,et al.  Contributions of serotonin in addiction vulnerability , 2011, Neuropharmacology.

[12]  E. V. Bockstaele,et al.  Collateralized dorsal raphe nucleus projections: A mechanism for the integration of diverse functions during stress , 2011, Journal of Chemical Neuroanatomy.

[13]  C. Lowry,et al.  Topographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylase , 2011, Neuroscience.

[14]  T. Dinan,et al.  Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders. , 2011, The international journal of neuropsychopharmacology.

[15]  C. Nemeroff,et al.  The role of corticotropin-releasing hormone in the pathophysiology of depression: therapeutic implications. , 2011, Current topics in medicinal chemistry.

[16]  K. Lesch,et al.  Cerebral metabolic responses to 5-HT2A/C receptor activation in mice with genetically modified serotonin transporter (SERT) expression , 2011, European Neuropsychopharmacology.

[17]  A. Grace,et al.  Hippocampus, amygdala, and stress: interacting systems that affect susceptibility to addiction , 2011, Annals of the New York Academy of Sciences.

[18]  C. Lowry,et al.  A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery , 2010, Proceedings of the National Academy of Sciences.

[19]  Alon Chen,et al.  Perifornical Urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis , 2010, Proceedings of the National Academy of Sciences.

[20]  F. Beuschlein,et al.  Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits , 2010, Molecular Psychiatry.

[21]  C. Barbui,et al.  Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants , 2010, BMJ : British Medical Journal.

[22]  I. Lucki,et al.  Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction , 2010, Brain Research.

[23]  Rupert Lanzenberger,et al.  The Serotonin-1A Receptor in Anxiety Disorders , 2009, Biological Psychiatry.

[24]  G. Forster,et al.  Corticotropin-Releasing Factor Receptor Antagonism within the Dorsal Raphe Nucleus Reduces Social Anxiety-Like Behavior after Early-Life Social Isolation , 2009, The Journal of Neuroscience.

[25]  T. Bale,et al.  Influence of sex and corticotropin-releasing factor pathways as determinants in serotonin sensitivity. , 2009, Endocrinology.

[26]  H. J. Olverman,et al.  Sex influences the effect of a lifelong increase in serotonin transporter function on cerebral metabolism , 2009, Journal of neuroscience research.

[27]  E. V. Bockstaele,et al.  Stress-Induced Redistribution of Corticotropin-Releasing Factor Receptor Subtypes in the Dorsal Raphe Nucleus , 2009, Biological Psychiatry.

[28]  C. Lowry,et al.  Acoustic stimulation in vivo and corticotropin-releasing factor in vitro increase tryptophan hydroxylase activity in the rat caudal dorsal raphe nucleus , 2009, Neuroscience Letters.

[29]  Anantha Shekhar,et al.  Serotonergic Systems, Anxiety, and Affective Disorder , 2008, Annals of the New York Academy of Sciences.

[30]  H. J. Olverman,et al.  Novel analysis for improved validity in semi-quantitative 2-deoxyglucose autoradiographic imaging , 2008, Journal of Neuroscience Methods.

[31]  C. Lowry,et al.  Evidence for serotonin synthesis-dependent regulation of in vitro neuronal firing rates in the midbrain raphe complex. , 2008, European journal of pharmacology.

[32]  C. Lowry,et al.  Corticotropin‐releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity , 2008, The European journal of neuroscience.

[33]  F. Weiss,et al.  The Dorsal Subiculum Mediates the Acquisition of Conditioned Reinstatement of Cocaine-Seeking , 2008, Neuropsychopharmacology.

[34]  E. Meloni,et al.  Activation of Raphe Efferents to the Medial Prefrontal Cortex by Corticotropin-Releasing Factor: Correlation with Anxiety-Like Behavior , 2008, Biological Psychiatry.

[35]  D. Finn,et al.  Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumption , 2008, Neuroscience.

[36]  C. H. Summers,et al.  Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbens. , 2008, European journal of pharmacology.

[37]  T. Sharp,et al.  Important messages in the 'post': recent discoveries in 5-HT neurone feedback control. , 2007, Trends in pharmacological sciences.

[38]  J. Neumaier,et al.  Chronic low dose ovine corticotropin releasing factor or urocortin II into the rostral dorsal raphe alters exploratory behavior and serotonergic gene expression in specific subregions of the dorsal raphe , 2007, Neuroscience.

[39]  O. Jahn,et al.  Differential activation of CRF receptor subtypes removes stress‐induced memory deficit and anxiety , 2007, The European journal of neuroscience.

[40]  E. Zorrilla,et al.  Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: Ancient CRF paralogs , 2007, Frontiers in Neuroendocrinology.

[41]  C. H. Summers,et al.  Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior , 2006, Neuroscience.

[42]  T. Sharp,et al.  In vivo evidence that 5‐HT2C receptors inhibit 5‐HT neuronal activity via a GABAergic mechanism , 2006, British journal of pharmacology.

[43]  S. O’Mara.  Controlling hippocampal output: The central role of subiculum in hippocampal information processing , 2006, Behavioural Brain Research.

[44]  W. Vale,et al.  The Effect of Lateral Septum Corticotropin-Releasing Factor Receptor 2 Activation on Anxiety Is Modulated by Stress , 2006, The Journal of Neuroscience.

[45]  E. V. Bockstaele,et al.  Differential projections of dorsal raphe nucleus neurons to the lateral septum and striatum , 2006, Journal of Chemical Neuroanatomy.

[46]  J. Gugten,et al.  Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain , 2006, Brain Research.

[47]  C. Lowry,et al.  Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons , 2006, Brain Research.

[48]  A. Shekhar,et al.  Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs , 2005, Neuroscience.

[49]  K. L. Gardner,et al.  Early life experience alters behavior during social defeat: Focus on serotonergic systems , 2005, Neuroscience.

[50]  A. Weitemier,et al.  Lesions of the Edinger-Westphal nucleus alter food and water consumption. , 2005, Behavioral neuroscience.

[51]  G. Abbadessa,et al.  Effects of swim stress and α-MSH acute pre-treatment on brain 5-HT transporter and corticosterone receptor , 2005, Pharmacology Biochemistry and Behavior.

[52]  T. Sharp,et al.  A role for midbrain raphe &ggr; aminobutyric acid neurons in 5-hydroxytryptamine feedback control , 2005, Neuroreport.

[53]  C. Lowry,et al.  Urocortin 2 increases c-Fos expression in topographically organized subpopulations of serotonergic neurons in the rat dorsal raphe nucleus , 2005, Brain Research.

[54]  K. Lewis,et al.  Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids. , 2005, Molecular endocrinology.

[55]  P. Shinnick‐Gallagher,et al.  Chronic Cocaine Administration Switches Corticotropin-Releasing Factor2 Receptor-Mediated Depression to Facilitation of Glutamatergic Transmission in the Lateral Septum , 2005, The Journal of Neuroscience.

[56]  Anders Hay-Schmidt,et al.  Modulation of anxiety circuits by serotonergic systems , 2005, Stress.

[57]  S. Maier,et al.  Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala , 2004, Neuroscience.

[58]  M. Nishiyama,et al.  Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system , 2004, Peptides.

[59]  S. Maier,et al.  Differential expression of 5HT‐1A, α1b adrenergic, CRF‐R1, and CRF‐R2 receptor mRNA in serotonergic, γ‐aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus , 2004 .

[60]  W. Vale,et al.  Selective Activation of Corticotropin-Releasing Factor-2 Receptors on Neurochemically Identified Neurons in the Rat Dorsal Raphe Nucleus Reveals Dual Actions , 2004, The Journal of Neuroscience.

[61]  W. Vale,et al.  CRF and CRF receptors: role in stress responsivity and other behaviors. , 2004, Annual review of pharmacology and toxicology.

[62]  B. Vanderbeek,et al.  Dexamethasone exposure during the neonatal period alters ORL1 mRNA expression in the hypothalamic paraventricular nucleus and hippocampus of the adult rat. , 2003, Brain research. Developmental brain research.

[63]  S. Maier,et al.  Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress , 2003, Behavioural Brain Research.

[64]  F. Holsboer,et al.  Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress , 2003, Nature Neuroscience.

[65]  G. Griebel,et al.  Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[66]  Michael Davis,et al.  Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. , 2003, European journal of pharmacology.

[67]  S. Maier,et al.  Corticotropin Releasing Hormone Type 2 Receptors in the Dorsal Raphe Nucleus Mediate the Behavioral Consequences of Uncontrollable Stress , 2003, The Journal of Neuroscience.

[68]  Hans-Jürgen Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision , 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[69]  T. Baram,et al.  Corticotropin-Releasing Hormone (CRH) Downregulates the Function of Its Receptor (CRF1) and Induces CRF1 Expression in Hippocampal and Cortical Regions of the Immature Rat Brain , 2002, Experimental Neurology.

[70]  N. Kalin,et al.  Reduction of Stress-Induced Behavior by Antagonism of Corticotropin-Releasing Hormone 2 (CRH2) Receptors in Lateral Septum or CRH1 Receptors in Amygdala , 2002, The Journal of Neuroscience.

[71]  F. Holsboer,et al.  Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. , 2002, Current opinion in pharmacology.

[72]  P. Celada,et al.  Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABAA, and Glutamate Receptors , 2001, The Journal of Neuroscience.

[73]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[74]  C. Donaldson,et al.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[75]  A. Hsueh,et al.  Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor , 2001, Nature Medicine.

[76]  J. Vaughan,et al.  Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[77]  P. Sawchenko,et al.  Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse , 2000, The Journal of comparative neurology.

[78]  S. Lightman,et al.  Corticotropin-Releasing Factor Increases In VitroFiring Rates of Serotonergic Neurons in the Rat Dorsal Raphe Nucleus: Evidence for Activation of a Topographically Organized Mesolimbocortical Serotonergic System , 2000, The Journal of Neuroscience.

[79]  O. Hermanson,et al.  Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2 , 2000, Nature Genetics.

[80]  Paul E. Sawchenko,et al.  Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress , 2000, Nature Genetics.

[81]  Susan E. Murray,et al.  Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2 , 2000, Nature Genetics.

[82]  K. Rice,et al.  Effects of Corticotropin-Releasing Factor on Neuronal Activity in the Serotonergic Dorsal Raphe Nucleus , 2000, Neuropsychopharmacology.

[83]  J. Vaughan,et al.  Urocortin Expression in Rat Brain: Evidence Against a Pervasive Relationship of Urocortin‐Containing Projections With Targets Bearing Type 2 CRF Receptors , 1999, The Journal of comparative neurology.

[84]  J John Mann,et al.  Role of the Serotonergic System in the Pathogenesis of Major Depression and Suicidal Behavior , 1999, Neuropsychopharmacology.

[85]  T. Insel,et al.  Autoradiographic and in situ hybridization localization of corticotropin‐releasing factor 1 and 2 receptors in nonhuman primate brain , 1999, The Journal of comparative neurology.

[86]  R. Vertes,et al.  Projections of the median raphe nucleus in the rat , 1999, The Journal of comparative neurology.

[87]  I. Lucki,et al.  Effects of Corticotropin-Releasing Factor on Brain Serotonergic Activity , 1998, Neuropsychopharmacology.

[88]  A. Arimura,et al.  Distribution of urocortin‐like immunoreactivity in the central nervous system of the rat , 1998, The Journal of comparative neurology.

[89]  T. Baram,et al.  Corticotropin releasing factor receptor type II (CRF2) messenger ribonucleic acid levels in the hypothalamic ventromedial nucleus of the infant rat are reduced by maternal deprivation. , 1997, Endocrinology.

[90]  C. Rampon,et al.  Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods , 1997, Neuroscience.

[91]  T. Sharp,et al.  Functional Mapping of Dorsal and Median Raphe 5‐Hydroxytryptamine Pathways in Forebrain of the Rat Using Microdialysis , 1997, Journal of neurochemistry.

[92]  David Lovejoy,et al.  Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor , 1995, Nature.

[93]  E. De Souza,et al.  Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[94]  K. Semba,et al.  Extent of colocalization of serotonin and GABA in the neurons of the rat raphe nuclei , 1995, Brain Research.

[95]  C. Donaldson,et al.  Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[96]  J. Seckl,et al.  Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. , 1995, Brain research. Molecular brain research.

[97]  T. Lovenberg,et al.  Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[98]  M. Hamon,et al.  Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse. , 1994, European journal of pharmacology.

[99]  T. Gray,et al.  Amygdaloid CRF Pathways: Role in Autonomic, Neuroendocrine, and Behavioral Responses to Stress , 1993, Annals of the New York Academy of Sciences.

[100]  K. Lewis,et al.  Expression cloning of a human corticotropin-releasing-factor receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[101]  R. Vertes.  A PHA‐L analysis of ascending projections of the dorsal raphe nucleus in the rat , 1991, The Journal of comparative neurology.

[102]  G. Fink,et al.  Central 5,7‐Dihydroxytryptamine Lesions Decrease Hippocampal Glucocorticoid and Mineralocorticoid Receptor Messenger Ribonucleic Acid Expression , 1990, Journal of neuroendocrinology.

[103]  M. Hamon,et al.  Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[104]  H. Steinbusch,et al.  The distribution and origin of serotonin‐containing fibers in the septal area: A combined immunohistochemical and fluorescent retrograde tracing study in the rat , 1982, The Journal of comparative neurology.

[105]  W. Vale,et al.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. , 1982, Science.

[106]  W. Vale,et al.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin , 1981 .

[107]  H. Steinbusch,et al.  Distribution of serotonin-immunoreactivity in the central nervous system of the rat—Cell bodies and terminals , 1981, Neuroscience.

[108]  H. Joosten,et al.  Localization of serotonin in the central nervous system by immunohistochemistry: Description of a specific and sensitive technique and some applications , 1978, Neuroscience.

[109]  F. Beuschlein,et al.  Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits , 2010, Molecular Psychiatry.

[110]  T. Baram,et al.  Corticotropin-Releasing Hormone (CRH) Downregulates the Function of Its Receptor (CRF 1 ) and Induces CRF 1 Expression in Hippocampal and Cortical Regions of the Immature Rat Brain , 2010 .

[111]  D. R. Britton,et al.  Effects of 5-HT-1A receptor agonists on CRF-induced behavior , 2005, Psychopharmacology.

[112]  A. C. Linthorst.  Chapter 4.6 – Stress, corticotropin-releasing factor and serotonergic neurotransmission , 2005 .

[113]  H. J. Harris,et al.  Intracellular Regeneration of Glucocorticoids by 11β-Hydroxysteroid Dehydrogenase (11β-HSD)-1 Plays a Key Role in Regulation of the Hypothalamic-Pituitary-Adrenal Axis: Analysis of 11β-HSD-1-Deficient Mice** The Wellcome Trust supported this work through a program grant (to J.J.M. and J.R.S.) and a , 2001, Endocrinology.

[114]  H. J. Harris,et al.  Intracellular Regeneration of Glucocorticoids by 11β-Hydroxysteroid Dehydrogenase (11β-HSD)-1 Plays a Key Role in Regulation of the Hypothalamic-Pituitary-Adrenal Axis: Analysis of 11β-HSD-1-Deficient Mice1 , 2001 .

[115]  G. Flügge.  Regulation of monoamine receptors in the brain: dynamic changes during stress. , 2000, International review of cytology.

[116]  A. Armario,et al.  Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level. , 1996, Neuroendocrinology.

[117]  E. D. De Souza,et al.  Autoradiographic localization of 3H‐paroxetine‐labeled serotonin uptake sites in rat brain , 1987, Synapse.

[118]  F. Bloom,et al.  Chemical and biological characterization of corticotropin releasing factor. , 1983, Recent progress in hormone research.